Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. PHOSPHATE MONOPOTASSIQUE RENAUDIN - PHOSPHATE DIPOTASSIQUE RENAUDIN (phosphate monopotassique)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

PHOSPHATE MONOPOTASSIQUE RENAUDIN - PHOSPHATE DIPOTASSIQUE RENAUDIN (phosphate monopotassique)

Medicine - Posted on Mar 05 2003 - Updated on Jun 12 2019
Active substance (DCI)
  • phosphate monopotassique
history (2)
  • 3/5/03

    PHOSPHATE MONOPOTASSIQUE RENAUDIN 136,10 mg/ml, solution pour perfusion (boîte de 10 ampoules de 10 ml)

    PHOSPHATE MONOPOTASSIQUE RENAUDIN 136,10 mg/ml, solution pour perfusion (boîte de 10 ampoules de 10 ml)
    CAV :
    54321
    icône flèche
  • 3/5/03

    PHOSPHATE DIPOTASSIQUE RENAUDIN 174,20 mg/ml, solution pour perfusion (boîte de 10 ampoules de 10 ml)

    PHOSPHATE DIPOTASSIQUE RENAUDIN 174,20 mg/ml, solution pour perfusion (boîte de 10 ampoules de 10 ml)
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • B05XA06
Manufacturer
RENAUDIN
Presentation

PHOSPHATE MONOPOTASSIQUE RENAUDIN 136,10 mg/ml, solution pour perfusion
boîte de 10 ampoules de 10 ml

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
TejPzCyjtucfMLmW